RxSight Names Mark Wilterding Finance Chief
I'm PortAI, I can summarize articles.
RxSight has appointed Mark Wilterding as its new chief financial officer, effective January 11, 2026. Wilterding brings over 25 years of financial leadership experience, having previously served as senior vice president of global finance at Edwards Lifesciences and worked at Medtronic, Citi, and Credit Suisse. The company confirmed that former CFO Shelley Thunen will continue to support RxSight in a consulting role.
Source: fidelity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments